AQP4 and neuromyelitis optica: Our study thus validates a concept that has been already suggested in NMO by several in vitro studies [12–14, 24] and in animal models based on passive transfer of AQP4-IgG in the periphery [33] or iterative injection of AQP4-IgG directly into the spinal cord [21, 34].